Mario Roederer

Q: What Schools Are Affiliated With Mario Roederer

Mario Roederer is affiliated with the following schools: University of California, Berkeley, Harvey Mudd College, Stanford University, Carnegie Mellon University, University of Alaska Fairbanks

Mario Roederer's AcademicInfluence.com Rankings

Mario Roederer

Biology

#5006

World Rank

#7384

Historical Rank

Immunology

#220

World Rank

#229

Historical Rank

biology Degrees

Download Badge

Biology

Mario Roederer's Degrees

PhD Immunology Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Mario Roederer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mario Roederer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. (2006) (1913)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (2010) (1653)
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. (2003) (1646)
T-cell quality in memory and protection: implications for vaccine design (2008) (1531)
A human memory T-cell subset with stem cell-like properties (2011) (1505)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major (2007) (1291)
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients (1999) (1216)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection (2005) (1151)
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. (2003) (987)
Seventeen-colour flow cytometry: unravelling the immune system (2004) (982)
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection (2006) (970)
Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. (1990) (936)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) (809)
SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets (2011) (755)
Phenotype and function of human T lymphocyte subsets: Consensus and issues (2008) (747)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing (2011) (730)
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine (2013) (693)
Emerging concepts in the immunopathogenesis of AIDS. (2009) (670)
The who's who of T‐cell differentiation: Human memory T‐cell subsets (2013) (667)
Glutathione deficiency is associated with impaired survival in HIV disease. (1997) (646)
A deep profiler's guide to cytometry. (2012) (591)
The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. (2002) (553)
Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. (2001) (545)
CD8 naive T cell counts decrease progressively in HIV-infected adults. (1995) (518)
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses (2007) (498)
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. (2015) (496)
11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity (2001) (494)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates (2003) (482)
Immunocompetent T‐Cells with a Memory‐Like Phenotype are the Dominant Cell Type Following Antibody‐Mediated T‐Cell Depletion (2005) (471)
A practical approach to multicolor flow cytometry for immunophenotyping. (2000) (452)
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells (2003) (442)
Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses (2005) (420)
T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis (2004) (405)
Glutathione deficiency and human immunodeficiency virus infection (1992) (394)
Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. (1990) (371)
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry (2006) (369)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation (2006) (353)
Rapid development of a DNA vaccine for Zika virus (2016) (340)
Single-cell technologies for monitoring immune systems (2014) (335)
HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. (2005) (331)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. (2006) (328)
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments (2012) (322)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge (2014) (318)
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles (2005) (310)
CD4 T follicular helper cell dynamics during SIV infection. (2012) (309)
Role of BCR affinity in T cell–dependent antibody responses in vivo (2002) (299)
Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates (2006) (289)
Superior T memory stem cell persistence supports long-lived T cell memory. (2013) (287)
Prevention of tuberculosis in macaques after intravenous BCG immunization (2020) (279)
The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection (2009) (279)
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination (2016) (277)
N‐acetylcysteine replenishes glutathione in HIV infection (2000) (263)
Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. (2000) (262)
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression (2008) (258)
Role of antigen receptor affinity in T cell–independent antibody responses in vivo (2002) (258)
Intracellular cytokine optimization and standard operating procedure (2006) (254)
Polyfunctional T cell responses are a hallmark of HIV‐2 infection (2008) (247)
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. (2001) (247)
Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations (2007) (246)
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo (2014) (243)
Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection (2010) (242)
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses (2016) (241)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial (2008) (236)
Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. (2006) (235)
The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis (2015) (232)
A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial (2006) (229)
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses 1 (2003) (225)
Standardization of cytokine flow cytometry assays (2005) (224)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. (2006) (224)
A new “Logicle” display method avoids deceptive effects of logarithmic scaling for low signals and compensated data (2006) (220)
Vaccination in Humans Generates Broad T Cell Cytokine Responses1 (2004) (219)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques (2017) (216)
Compensation in Flow Cytometry (2002) (207)
Elevation of plasma thioredoxin levels in HIV-infected individuals. (1996) (206)
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. (2010) (202)
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. (2011) (202)
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge (2006) (201)
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs (2006) (200)
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates (2011) (199)
Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression (2006) (198)
High‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses (2011) (197)
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. (2007) (197)
Data analysis in flow cytometry: The future just started (2010) (196)
Beyond six colors: A new era in flow cytometry (2003) (195)
Chimpanzee Adenovirus Vector Ebola Vaccine (2017) (192)
Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. (1991) (191)
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial (2016) (190)
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge (2011) (190)
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection (2017) (188)
Quality assurance for polychromatic flow cytometry (2006) (185)
Optimizing a multicolor immunophenotyping assay. (2007) (182)
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (2016) (182)
Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. (2001) (181)
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates (2021) (176)
α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection (2009) (176)
Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. (1995) (175)
Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells (2012) (175)
Probability binning comparison: a metric for quantitating univariate distribution differences. (2001) (173)
Interpretation of cellular proliferation data: Avoid the panglossian (2011) (171)
Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. (2010) (166)
A chromatic explosion: the development and future of multiparameter flow cytometry (2008) (166)
Ontogeny of γδ T Cells in Humans (2004) (166)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. (2007) (166)
Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection (2009) (165)
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. (2007) (165)
N-acetylcysteine: a new approach to anti-HIV therapy. (1992) (164)
Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. (1992) (163)
Loss of Circulating CD4 T Cells with B Cell Helper Function during Chronic HIV Infection (2014) (163)
8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. (1997) (159)
Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. (2005) (154)
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques. (2011) (153)
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease (2020) (153)
The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration (2004) (151)
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses (2010) (147)
Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV (2013) (143)
Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost Vaccination (2010) (138)
HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. (1997) (134)
T cell assays and MIATA: the essential minimum for maximum impact. (2012) (134)
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants (2021) (133)
Cytometry: today's technology and tomorrow's horizons. (2012) (131)
Use of Escherichiu coli (E. coli) lacZ (β-Galactosidase) as a Reporter Gene. (1991) (131)
CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses (1991) (125)
Antioxidants inhibit stimulation of HIV transcription. (1993) (124)
Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells (2002) (122)
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. (2015) (121)
Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection1 (2009) (119)
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species (2010) (117)
Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004) (114)
Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection (2011) (113)
Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates. (2010) (112)
Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10‐year retrospective study (1988) (112)
Alpha and Lambda Interferon Together Mediate Suppression of CD4 T Cells Induced by Respiratory Syncytial Virus (2006) (112)
Resting naïve CD4+ T cells are massively infected and eliminated by X4-tropic simian–human immunodeficiency viruses in macaques (2005) (110)
Quality assurance for polychromatic flow cytometry using a suite of calibration beads (2012) (108)
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. (2001) (108)
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV (2018) (108)
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial (2015) (103)
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization (2013) (101)
Expression of CD 57 defines replicative senescence and antigen-induced apoptotic death of CD 8 T cells (2003) (99)
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron (2022) (98)
Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. (2012) (97)
Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans (2005) (97)
Innate and adaptive immune traits are differentially affected by genetic and environmental factors (2017) (96)
Probability binning comparison: a metric for quantitating multivariate distribution differences. (2001) (95)
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform (2010) (95)
Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point1 (2009) (93)
Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines (2011) (92)
Immunologic and virologic events in early HIV infection predict subsequent rate of progression. (2010) (92)
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals. (2007) (92)
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (92)
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. (2009) (90)
Brilliant violet fluorophores: A new class of ultrabright fluorescent compounds for immunofluorescence experiments (2012) (90)
Flow cytometry strikes gold (2015) (90)
Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR 2 (90)
Autocrine Production of β-Chemokines Protects CMV-Specific CD4+ T Cells from HIV Infection (2009) (89)
Cell-by-cell autofluorescence correction for low signal-to-noise systems: application to epidermal growth factor endocytosis by 3T3 fibroblasts. (1986) (89)
Frequency difference gating: a multivariate method for identifying subsets that differ between samples. (2001) (89)
Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge (2014) (86)
Quantifying spillover spreading for comparing instrument performance and aiding in multicolor panel design (2013) (85)
Cy7PE and Cy7APC: bright new probes for immunofluorescence. (1996) (84)
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. (2015) (84)
How many events is enough? Are you positive? (2008) (84)
Flow cytometric analysis of vaccine responses: how many colors are enough? (2004) (83)
Data File Standard for Flow Cytometry, version FCS 3.1 (2009) (82)
Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays (2012) (81)
Amine‐Reactive Dyes for Dead Cell Discrimination in Fixed Samples (2010) (80)
Getting to the HAART of T cell dynamics (1998) (78)
Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach (2008) (77)
T-cell dynamics of immunodeficiency (1995) (76)
T-cell dynamics during acute SIV infection (2003) (76)
N-acetylcysteine inhibits latent HIV expression in chronically infected cells. (1991) (76)
Beta-galactosidase activity in single differentiating bacterial cells. (1993) (76)
Ontogeny of gamma delta T cells in humans. (2004) (76)
Good cell, bad cell: Flow cytometry reveals T‐cell subsets important in HIV disease (2010) (76)
Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. (2005) (74)
IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. (2015) (72)
Neutralization tiers of HIV-1 (2017) (70)
Long-term depletion of naive T cells in patients treated for Hodgkin's disease. (1997) (69)
Highly multiplexed quantitation of gene expression on single cells. (2013) (68)
Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. (1999) (67)
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates (2010) (66)
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron (2022) (65)
DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial (2013) (65)
Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. (2003) (65)
Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (2009) (63)
Mixture models for single-cell assays with applications to vaccine studies. (2012) (63)
Genetic immunization in the lung induces potent local and systemic immune responses (2010) (63)
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates (2021) (62)
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow. (2009) (61)
Optimized determination of T cell epitope responses. (2003) (61)
HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins (2012) (60)
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion (2019) (60)
RchyOptimyx: Cellular hierarchy optimization for flow cytometry (2012) (59)
Increased IL-15 Production Is Associated with Higher Susceptibility of Memory CD4 T Cells to Simian Immunodeficiency Virus during Acute Infection12 (2009) (59)
Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication. (1994) (59)
Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects (2007) (58)
Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency (2008) (57)
Techniques to improve the direct ex vivo detection of low frequency antigen‐specific CD8+ T cells with peptide‐major histocompatibility complex class I tetramers (2008) (57)
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. (2019) (55)
N-acetylcysteine: potential for AIDS therapy. (1993) (54)
Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. (2001) (53)
Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. (2001) (53)
Magnitude and Quality of Vaccine-Elicited T-Cell Responses in the Control of Immunodeficiency Virus Replication in Rhesus Monkeys (2008) (52)
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire. (2013) (52)
Publishing flow cytometry data. (2010) (52)
Publication of optimized multicolor immunofluorescence panels (2010) (51)
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition (2018) (51)
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation (2018) (49)
Vδ1 and Vδ2 γδ T cells express distinct surface markers and might be developmentally distinct lineages (2001) (48)
OMIP‐017: Human CD4+ helper T‐cell subsets including follicular helper cells (2013) (48)
CCR2 Identifies a Stable Population of Human Effector Memory CD4+ T Cells Equipped for Rapid Recall Response (2010) (48)
Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. (1997) (47)
Virus Inhibition Activity of Effector Memory CD8+ T Cells Determines Simian Immunodeficiency Virus Load in Vaccinated Monkeys after Vaccine Breakthrough Infection (2012) (47)
Flow cytometry and the future of vaccine development (2009) (47)
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (47)
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates (2021) (47)
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections (2009) (46)
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120 (2017) (45)
Gating‐ML: XML‐based gating descriptions in flow cytometry (2008) (45)
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults (2011) (44)
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates (2015) (44)
IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. (2011) (44)
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung (2021) (43)
Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge (2011) (41)
Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. (1996) (41)
A Mine Is a Terrible Thing to Waste: High Content, Single Cell Technologies for Comprehensive Immune Analysis (2015) (41)
Disregulation of Leukocyte Glutathione in AIDS (1993) (40)
mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates (2021) (40)
Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. (2008) (40)
Differential Impact of Magnitude, Polyfunctional Capacity, and Specificity of HIV-Specific CD8+ T Cell Responses on HIV Set Point (2013) (40)
flowClean: Automated identification and removal of fluorescence anomalies in flow cytometry data (2016) (40)
CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. (1991) (38)
Optimizing peptide matrices for identifying T‐cell antigens (2008) (38)
Replication-Defective Adenovirus Vectors with Multiple Deletions Do Not Induce Measurable Vector-Specific T Cells in Human Trials (2009) (38)
Flow cytometric DNA analysis of adrenocortical tumors in children (1987) (37)
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates (2015) (37)
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth (2020) (37)
Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation (2018) (37)
Trafficking, Persistence, and Activation State of Adoptively Transferred Allogeneic and Autologous Simian Immunodeficiency Virus-Specific CD8+ T Cell Clones during Acute and Chronic Infection of Rhesus Macaques (2009) (37)
The use of quantum dot nanocrystals in multicolor flow cytometry. (2010) (37)
CD4 T cell subsets in the mucosa are CD28+Ki‐67−HLA‐DR−CD69+ but show differential infection based on α4β7 receptor expression during acute SIV infection (2009) (36)
Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8+ T Cell Clones in Rhesus Macaques during Acute Infection (2009) (36)
FACS-Gal: Flow cytometric analysis and sorting of cells expressing reporter gene constructs (1991) (36)
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (2021) (35)
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques (2019) (35)
OMIPs—Orchestrating multiplexity in polychromatic science (2010) (35)
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (2021) (35)
Increased immunofluorescence sensitivity using 532 nm laser excitation (2007) (35)
Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8+ T-Cell Differentiation (2012) (34)
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. (2014) (34)
Infectious Molecular Clones from a Simian Immunodeficiency Virus-Infected Rapid-Progressor (RP) Macaque: Evidence of Differential Selection of RP-Specific Envelope Mutations In Vitro and In Vivo (2006) (33)
Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates (2012) (33)
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies. (2012) (33)
Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages. (2001) (33)
Antiretroviral Therapy prior to Acute Viral Replication Preserves CD4 T Cells in the Periphery but Not in Rectal Mucosa during Acute Simian Immunodeficiency Virus Infection (2008) (32)
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates (2021) (32)
Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge (2018) (31)
Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms (2008) (31)
The impact of HLA class I and EBV latency‐II antigen‐specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma (2015) (31)
Heterogeneous calcium flux in peripheral T cell subsets revealed by five-color flow cytometry using log-ratio circuitry. (1995) (31)
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition (2016) (31)
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes (2018) (30)
Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques (2021) (30)
OMIP‐001: Quality and phenotype of Ag‐responsive human T‐cells (2010) (30)
Endosomes can undergo an ATP-dependent density increase in the absence of dense lysosomes. (1990) (30)
OMIP‐060: 30‐Parameter Flow Cytometry Panel to Assess T Cell Effector Functions and Regulatory T Cells (2019) (30)
Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design (2017) (29)
Multiparameter FACS analysis. (2002) (29)
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants (2021) (29)
OMIP‐051 – 28‐color flow cytometry panel to characterize B cells and myeloid cells (2018) (29)
Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge (2006) (28)
Measuring containment of viable infectious cell sorting in high‐velocity cell sorters (2003) (28)
Background fluorescence and spreading error are major contributors of variability in high‐dimensional flow cytometry data visualization by t‐distributed stochastic neighboring embedding (2018) (28)
Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: Implications for HIV immunopathogenesis (2007) (26)
Glutathione and Immunophenotypes of T and B Lymphocytes in HIV‐Infected Individuals a (1992) (26)
Guidelines for the presentation of flow cytometric data. (2004) (26)
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses (2017) (26)
ET-18-OCH3 Inhibits Nuclear Factor-κB Activation by 12-O-Tetradecanoylphorbol-13-acetate but not by Tumor Necrosis Factor-α or Interleukin 1α (1995) (26)
A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine (2014) (25)
Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling. (2004) (25)
OMIP‐015: Human regulatory and activated T‐cells without intracellular staining (2013) (24)
Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge. (2011) (24)
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens (2016) (23)
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease (2021) (23)
Measurement of antigen specific immune responses: 2006 update (2007) (23)
Blocking α4β7 integrin binding to SIV does not improve virologic control (2019) (23)
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost (2018) (22)
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Prima (2017) (22)
Heavy metal contaminants can eliminate quantum dot fluorescence (2011) (22)
Q and B values are critical measurements required for inter‐instrument standardization and development of multicolor flow cytometry staining panels (2014) (22)
OMIP‐005: Quality and phenotype of antigen‐responsive rhesus macaque T cells (2012) (22)
A deadly dance: the choreography of host–pathogen interactions, as revealed by single-cell technologies (2018) (22)
Flow cytometry dna ploidy analysis and catecholamine secretion profiles in neuroblastoma (1990) (22)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7 (2018) (21)
Increased Memory Differentiation Is Associated with Decreased Polyfunctionality for HIV but Not for Cytomegalovirus-Specific CD8+ T Cells (2012) (21)
IL-15 Expands Unconventional CD8ααNK1.1+ T Cells but Not Vα14Jα18+ NKT Cells1 (2008) (21)
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality (2020) (21)
The Flow Cytometry Shared Resource Laboratory: Best practices to assure a high‐quality, cost‐effective partnership with biomedical research laboratories (2009) (21)
Compensation is not dependent on signal intensity or on number of parameters. (2001) (20)
Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses. (2011) (20)
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques (2016) (20)
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011) (2014) (20)
Filarial Infection Modulates the Immune Response to Mycobacterium tuberculosis through Expansion of CD4+ IL-4 Memory T Cells (2015) (20)
Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells (2017) (19)
Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIVmac251 in the Gut (2007) (19)
SIV-specific CD 8 T cells express high levels of PD 1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac 251 infection (2007) (19)
Effect of confluence on endocytosis by 3T3 fibroblasts: increased rate of pinocytosis and accumulation of residual bodies. (1989) (19)
Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method (2011) (18)
Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors (2016) (18)
147 Rational Design of Envelope Surface Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 (2011) (17)
Vaccination induces HIV broadly neutralizing antibody precursors in humans (2022) (17)
Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques. (2017) (17)
Enzyme-generated intracellular fluorescence for single-cell reporter gene analysis utilizing Escherichia coli beta-glucuronidase. (1996) (16)
Distributions of autofluorescence after compensation: Be panglossian, fret not (2016) (16)
Phycoerythrin-allophycocyanin: a resonance energy transfer fluorochrome for immunofluorescence. (2001) (16)
Single Cell Analysis and Selection of Living Retrovirus Vector-corrected Mucopolysaccharidosis VII Cells Using a Fluorescence-activated Cell Sorting-based Assay for Mammalian β-Glucuronidase Enzymatic Activity* (1999) (16)
Estimating the Impact of Vaccination on Acute Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections (2008) (16)
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates. (2013) (16)
Polychromatic plots: Graphical display of multidimensional data (2008) (16)
Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy (2016) (15)
Naïve CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells (2001) (15)
OMIP‐013: Differentiation of human T‐cells (2012) (15)
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector (2019) (15)
Application of quantum dots to multicolor flow cytometry. (2007) (15)
Viable infectious cell sorting in a BSL-3 facility. (2004) (15)
The peripheral differentiation of human natural killer T cells (2019) (14)
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection (2019) (14)
Early immunologic and virologic predictors of clinical HIV-1 disease progression (2013) (14)
OMIP‐029: Human NK‐cell phenotypization (2015) (14)
Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate (2019) (14)
Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study (2015) (14)
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes (2019) (14)
Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases (2020) (14)
IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells. (2008) (13)
Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining (2021) (13)
The colorful future of cell analysis by flow cytometry. (2004) (13)
T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette–Guérin Vaccination (2021) (13)
A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients (2018) (13)
Emerging Concepts in the Immunopathogenesis (2009) (13)
ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. (1995) (13)
A single, continuous metric to define tiered serum neutralization potency against HIV (2018) (13)
Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures. (2018) (13)
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial (2022) (12)
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY (2015) (12)
Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates (2012) (12)
Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models (2015) (12)
OMIP‐058: 30‐Parameter Flow Cytometry Panel to Characterize iNKT, NK, Unconventional and Conventional T Cells (2019) (12)
Acute HIV infection: it takes more than guts (2006) (12)
Measuring Antigen‐Specific Immune Responses, 2008 update (2008) (11)
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors (2021) (11)
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection. (2020) (11)
Immunophenotyping of T Cell Subpopulations in HIV Disease (2005) (11)
T-cell quality in memory and protection: implications for vaccine design (2008) (11)
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC (2018) (11)
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates (2021) (11)
OMIP‐009: Characterization of antigen‐specific human T‐cells (2012) (11)
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues (2022) (10)
Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy Women (2021) (10)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7 (2018) (10)
Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait. (2022) (10)
A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types. (2004) (10)
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway (2021) (10)
CD 8 Naive T Cell Counts Decrease Progressively in HIV-infected Adults (2013) (10)
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields. (2019) (9)
A simple tube adapter to expedite and automate thawing of viably frozen cells. (2016) (9)
OMIP‐002: Phenotypic analysis of specific human CD8+ T‐cells using peptide‐MHC class I multimers for any of four epitopes (2010) (9)
Deconvoluting virome-wide antibody epitope reactivity profiles (2021) (9)
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates (2020) (9)
CD20 expression is increased on B lymphocytes from HIV-infected individuals. (1992) (9)
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates (2021) (9)
Intracellular thiols regulate activation of nuclear factor KCB and transcription of human immunodeficiency virus ( transcription factor / glutathione / signal transduction / AIDS / N-acetyl-L-cysteine ) (8)
OMIP‐019: Quantification of human γδT‐cells, iNKT‐cells, and hematopoietic precursors (2013) (8)
Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial (2014) (7)
Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
preferentially reside in the bone marrow (2008) (7)
Antiviral Antibody Epitope Selection is a Heritable Trait (2021) (7)
Early treatment with reverse transcriptase inhibitors significantly suppresses peak plasma IFNα in vivo during acute simian immunodeficiency virus infection. (2016) (7)
Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV (2021) (7)
Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition (2014) (6)
Optimizing a Multi-colour Immunophenotyping Assay (2007) (6)
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses. (2022) (6)
A proposal for unified flow cytometer parameter naming (2015) (6)
Multiple stained samples are not appropriate compensation controls (2011) (6)
OMIP‐068: High‐Dimensional Characterization of Global and Antigen‐Specific B Cells in Chronic Infection (2020) (5)
Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries (2022) (5)
Cytometry : new developments (2004) (5)
Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates (2019) (5)
Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques (2020) (5)
Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination (2016) (5)
Biohazard sorting. (2004) (5)
Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques. (2018) (5)
Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly (2021) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Identification of human viral protein-derived ligands recognized by individual major histocompatibility complex class I (MHCI)-restricted T-cell receptors (2016) (4)
T cell responses in nonhuman primates + quality of Th 1 and CD 8 HIV Gag protein conjugated to a Toll-like receptor 7 / 8 agonist improves the magnitude and Mattapallil (2007) (4)
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques (2021) (4)
A conversation with Leonard and Leonore Herzenberg. (2014) (4)
VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP) (2005) (4)
Correction for Kibler et al., “Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC” (2019) (4)
The Interrelationship of Tumor Necrosis Factor, Glutathione, and AIDS (1992) (4)
Cryo-EM structures of prefusion SIV envelope trimer (2022) (3)
ZEBU CROSSES IN TUNISIA (1915) (3)
Multifunctional analysis of antigen-specific T cells: correlates of vaccine efficiency (2010) (3)
Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine (2012) (3)
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center (2021) (3)
CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus (2019) (3)
Prevalence, persistence, and genetics of antibody responses to protein toxins and virulence factors (2021) (3)
The Simian Immunodeficiency Virus Targets Central Cell Cycle Functions through Transcriptional Repression In vivo (2011) (3)
Immune phenotypes that predict COVID-19 severity (2022) (3)
CCR5 and HIV: the less, the better (2007) (3)
Standard practice for cell sorting in a BSL-3 facility. (2011) (3)
Leonard Herzenberg (1931–2013) (2013) (2)
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (2016) (2)
Delineating tissue-specific alloimmunity during acute GVHD (2018) (2)
Direct Measurement of CD41 and CD81 T-Cell Responses to CMV in HIV-1-Infected Subjects (2001) (2)
Real-time killing assays to assess the potency of a new anti-SIV CAR. (2020) (2)
V d 1 and V d 2 gd T cells express distinct surface markers and might be developmentally distinct lineages (2001) (2)
S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers (2009) (2)
Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples (2022) (2)
Systematic identification of genomic elements that regulate FCGR2A expression and harbor variants linked with autoimmune disease. (2021) (2)
Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T Cell (2020) (2)
mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates (2021) (2)
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against (1998) (2)
Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques (2021) (2)
A high throughput lentivirus sieving assay identifies neutralization resistant Envelope sequences and predicts in vivo sieving. (2019) (2)
Mucosa and vaccine-induced immune protection in nonhuman primates (2008) (2)
Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition (2023) (1)
141 The Role of T Memory Stem Cells: Pathogenesis and Vaccines (2012) (1)
Extensive CD8β depletion does not prevent control of viral replication or protection from challenge in macaques chronically infected with a live attenuated simian immunodeficiency virus (2019) (1)
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV (2018) (1)
Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses (2012) (1)
P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011) (2009) (1)
Reporters of Gene Expression: Enzymatic Assays (1998) (1)
OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption (2022) (1)
Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells. (2007) (1)
P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen (2009) (1)
RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues (2012) (1)
Endosomal pH Regulation and the Maturation Model for Lysosome Biogenesis (1992) (1)
Highly Multiplexed, Single Cell Transcriptomic Analysis of T-Cells by Microfluidic PCR. (2017) (1)
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates (2021) (1)
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial. (2023) (1)
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques (2019) (1)
Leonard Herzenberg (1931-2013): the life of FACS. (2013) (1)
Polychromatic Flow Cytometry (2006) (1)
Tissue Trafficking Kinetics of Rhesus Macaque Natural Killer Cells Measured by Serial Intravascular Staining (2022) (1)
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study (2022) (1)
Abstract 3962: High-dimensional flow cytometric immune profiling of malignant gliomas (2017) (1)
HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env (2012) (1)
Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates (2019) (1)
Human-, Simian-, and Chimpanzee-Derived T Cells following + Gag-Specific CD8 of Simian Immunodeficiency Virus Quality, Phenotype, and Protective Capacity Comparative Analysis of the Magnitude, (2013) (0)
Leveraging high-dimensional flow cytometry to reveal the human immune system at a population-wide scale (2021) (0)
2347. Blood Transcriptional Correlates of Vaccine-Induced Protection Against TB in Macaques (2022) (0)
T Cells in HIV Infection + CD 8 Death-1 and CD 57 with Ex Vivo Survival of Differential Association of Programmed (2009) (0)
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition (2018) (0)
Employing Improved Antigens Allows Streamlining of Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques (2016) (0)
Immunology of T Cells in AIDS: Dynamics Revealed by Eight-Color Flow Cytometry (2020) (0)
Expression of CD40L by the ALVAC-SIV vector abrogates T cell responses in 1 macaques 2 (2020) (0)
P16-28. The first year: early correlates of long-term HIV progression (2009) (0)
Development of a 30-parameter flow cytometry panel for functional characterization of unconventional T cells and innate lymphoid cells (2021) (0)
Data quality in the study of the mechanisms of extracorporeal photochemotherapy. (2011) (0)
, In Vivo Infection Improves Protection against Lentiviral In Vitro Neutralizing HIV-1 Antibody Enhanced Potency of a Broadly (2014) (0)
Defining the relationship between lipids and immune traits in TwinsUK (2021) (0)
CCR2 identifies first responders among human CD4+ memory T cells: long-lived, apoptosis-resistant, antigen-responsive cells with enhanced migration potential, a low threshold for activation, and immediate effector capabilities (85.5) (2007) (0)
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4 (2022) (0)
Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection (2015) (0)
Architecture of Mutualistic and Trophic Networks Stability of Ecological Communities and the (2010) (0)
Title Employing Improved Antigens Allows Streamlining of Heterologous DNA-Prime and NYVAC / Protein-Boost HIV Vaccine Regimens in Rhesus Macaques Running title : Improved HIV Antigens and Delivery Schedules in Macaques (2015) (0)
Cytomegalovirus-Specific CD 8 for HIV but Not for Associated with Decreased Polyfunctionality Increased Memory Differentiation (2012) (0)
Mixture Models for Single-Cell Assays with Application to Vaccine Studies : Supplementary Materials (2013) (0)
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease (2020) (0)
A deadly dance: the choreography of host–pathogen interactions, as revealed by single-cell technologies (2018) (0)
Material for Adjuvant dependent innate and adaptive immune signatures of risk of SIVmac 251 acquisition (2016) (0)
152: CD8 T cell responses correlate with antigen but are independent of type I IFN and STING signaling after adenoviral vaccination (2014) (0)
Probing Immune Responses: The Role of Intracellular Glutathione (1996) (0)
The role of lymphocyte subsets in preventing tuberculosis following intravenous vaccination with BCG (2022) (0)
Differential Speciﬁcity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (cid:1) (2009) (0)
P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates (2009) (0)
Rapid development of a DNAvaccine for Zika virus (2016) (0)
Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques (2021) (0)
Multi-omic analyses reveal antibody-dependent natural killer cell-mediated cytotoxicity in autoimmune thyroid diseases (2019) (0)
Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses (2012) (0)
Immunotherapy of Lymphomatoid Granulomatosis (2022) (0)
MacaquesAcute and Chronic Infection of Rhesus T Cell Clones during + Virus-Specific CD8 Autologous Simian Immunodeficiency of Adoptively Transferred Allogeneic and Trafficking, Persistence, and Activation State (2009) (0)
Increased immune activation during chronic SIV infection drives the TFH dynamics. (105.33) (2012) (0)
IMMU-68. SINGLE-CELL PROTEOMIC ANALYSIS OF IMMUNE CELL RESPONSE TO CHECKPOINT BLOCKADE USING 30-PARAMETER FLOW CYTOMETRY (2018) (0)
Mouth as a Window on the Changing Natural History of HIV Infection (2000) (0)
Reduced Protection from Simian Immunodeﬁciency Virus SIV mac251 Infection Afforded by Memory CD8 (cid:1) T Cells Induced by Vaccination during CD4 (cid:1) T-Cell Deﬁciency (cid:1) (2008) (0)
Distinct Subpopulations of Human Peripheral Blood Monocytes Characterized by Absence of the CD14 Surface Marker, and Distinguished by High or Low Intracellular Glutathione (1993) (0)
HIV vaccines: can mucosal CD4 T cells be protected? (2006) (0)
126 Broadly Neutralizing HIV Abs: Gains and Losses in Translation (2012) (0)
Vaccine-induced temporal cross-talk between myeloid cells reduces the risk of SIVmac251 acquisition (2017) (0)
Neutralization tiers of HIV-1 The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2018) (0)
nonhuman primates Transient and persistent effects of IL-15 on lymphocyte homeostasis in (2011) (0)
CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults (2011) (0)
Chagasic cardiomyopathy is marked by a unique signature of activated CD4+ T cells (2022) (0)
Erratum: Genetic immunization in the lung induces potent local and systemic immune responses (Proceedings of the National Academy of Sciences of the United States of America (2010) 107 (22213-22218) DOI: 10.1073/pnas.1015536108) (2011) (0)
High Avidity Leukemia-Associated Antigen-Specific CD8+ T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies. (2007) (0)
Age but not disease progression defines CD4+ and CD8+ T stem cell memory levels in human retroviral infections: contrasting effects of HTLV-1 and HIV-1 (2018) (0)
Identi fi cation of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors (2016) (0)
Multivariate Analysis Establishes Airway T Cells as a Correlate of IV BCG-Mediated Protection Against Tuberculosis in Rhesus Macaques (2022) (0)
D-107 Antigenic Heterogeneity of Clonal Envelopes: A Novel Immune Evasion Mechanism (2014) (0)
Correction: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (2016) (0)
ID: 239: A functional FAS polymorphism links CD4 T stem cell memory levels and IFN-induced apoptosis in both healthy controls and Adult T-cell Leukemia patients (2015) (0)
High avidity myeloid leukemia-associated antigen-speciﬁc CD8 (cid:1) T cells preferentially reside in the bone marrow (2009) (0)
Streamlining Heterologous DNA-Prime and NYVAC / Protein-Boost HIV Vaccine Regimens in 1 Rhesus Macaques by Employing Improved Antigens 2 3 (2016) (0)
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys (2009) (0)
フロ-サイトメトリ-自由自在(7)FACSの細胞生物学への応用(2)リンパ球サブセットに対する多重染色解析--8カラ-解析で十分か? (1998) (0)
Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques (2021) (0)
Intravenous Bacille Calmette-Guerin provides protection across a dose spectrum in a Rhesus macaque model of tuberculosis (2019) (0)
UNCOVERING ASSOCIATIONS BETWEEN BLOOD PRESSURE PHENOTYPES AND IMMUNE TRAITS IN TWINSUK (2021) (0)
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming. (2023) (0)
Vaccine-Elicited T cells are Important for Intravenous BCG Mediated Protection in a Rhesus macaque Model of Tuberculosis (2020) (0)
Flux in Peripheral T Cell by Five-Color Flow Cytometry Using Log-Ratio Circuitry (1995) (0)
impaired proliferative capacity in acute and chronic SIVmac251 infection SIV-specific CD8+T-cells express high levels of PD1 and cytokines but have (2013) (0)
[Attempt to treat the continuous suppurative acrodermatitis of Hallopeau by cortisone]. (1954) (0)
Uncovering the Molecular Signature of Pathogenic Tissue-Infiltrating T Cells during Acute Graft-Versus-Host Disease (2018) (0)
Depressed lymphocyte glutathione levels in patients with septic shock (1999) (0)
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center (2021) (0)
Dictated by Cognate Peptide Concentration T Cell Effector Activity Is + Antiviral CD8 The Functional Profile of Primary Human (2004) (0)
tuberculosis Mycobacterium Protect against High-Dose Lungs of Rhesus Macaques but Fails To Robust Cellular Immune Responses in the Aerosol Vaccination with AERAS-402 Elicits (2014) (0)
Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for CMV-specific CD 8 + T cells (2012) (0)
Intravenous BCG protects SIV+ macaques from tuberculosis. (2021) (0)
Abstract A11: Ipilimumab protects T cells from the antiproliferative effects of dexamethasone (2018) (0)
Blood Transcriptional Correlates of BCG-Induced Protection Against Tuberculosis in Rhesus Macaques (2022) (0)
[The treatment of syphilis by penicillin only, as practiced currently by North American physicians]. (1951) (0)
Single-cell transcriptome of in vivo SIV-infected rhesus macaque CD4 T cells (2019) (0)
A meta-analysis of passive immunization studies shows an association of serum neutralizing antibody titer with protection against SHIV challenge (2019) (0)
PS-P13-6: DEFINING THE RELATIONSHIP BETWEEN IMMUNE TRAITS AND LIPIDS IN TWINSUK (2023) (0)
Human Immunodeﬁciency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells (2002) (0)
Potent SIV-specific Antibodies Targeting the Cyanovirin Binding Site (2014) (0)
IL-15 Expands Unconventional CD8 (2008) (0)
Spatiotemporal single-cell profiling of gastrointestinal GVHD reveals invasive and resident memory T cell states (2020) (0)
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques (2023) (0)
CCR5 and HIV: the less, the better Complexity at the junction (2007) (0)
Prevention of tuberculosis in macaques after intravenous BCG immunization (2020) (0)
Equipped for Rapid Recall Response T Cells + Human Effector Memory CD4 CCR2 Identifies a Stable Population of (2010) (0)
Applications of high-throughput single B-cell sequencing to accelerate rational vaccine design (2016) (0)
Acute infection by SIV: massive immunological damage (2006) (0)
Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node. (2023) (0)
[Sacrolisthesis; diagnosis and etiology; the question of hierolisthesis [sacrolisthesis]. (1950) (0)
Set Point T Cell Responses on HIV + HIV-Specific CD8 Polyfunctional Capacity, and Specificity of Differential Impact of Magnitude, (2014) (0)
Technical Advance Highly Tissue Substructure-Specific Effects of Human Papilloma Virus in Mucosa of HIV-Infected Patients Revealed by Laser-Dissection Microscopy-Assisted Gene Expression Profiling (2004) (0)
HLA-Class I Alleles Impact Susceptibility To EBV+ Classical Hodgkin Lymphoma By Altering EBV Latent Antigen-Specific CD8+ T-Cell Immune Hierarchies (2013) (0)
RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues (2012) (0)
Title: Immune Correlates of Protection by mRNA-1273 Immunization against 1 SARS-CoV-2 Infection in Nonhuman Primates (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mario Roederer?

Mario Roederer is affiliated with the following schools:

Mario Roederer's Academic­Influence.com Rankings